Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NDMC in UVB-induced pain model
NCT03375034Phase 1Completed
- Start
- Mar 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of n-desmethylclobazam in neuropathic pain (4 arms). Primary endpoint: Change in the area of secondary hyperalgesia from baseline at 10 hours. Started Mar 2017; status: completed.
02
Drugs
n-desmethylclobazam
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03375034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375034.